Omeros Corp (OMER)
3.065
-0.01
(-0.33%)
USD |
NASDAQ |
Apr 24, 10:39
Omeros Price: 3.065 for April 24, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 23, 2024 | 3.11 | 3.25 | 3.07 | 3.075 | 189117.0 |
Apr 22, 2024 | 3.16 | 3.16 | 3.00 | 3.08 | 291626.0 |
Apr 19, 2024 | 3.17 | 3.25 | 3.025 | 3.05 | 385938.0 |
Apr 18, 2024 | 3.32 | 3.41 | 3.195 | 3.21 | 429230.0 |
Apr 17, 2024 | 3.48 | 3.565 | 3.32 | 3.34 | 269409.0 |
Apr 16, 2024 | 3.39 | 3.48 | 3.28 | 3.43 | 237162.0 |
Apr 15, 2024 | 3.71 | 3.82 | 3.36 | 3.38 | 432495.0 |
Apr 12, 2024 | 3.93 | 4.10 | 3.722 | 3.76 | 304756.0 |
Apr 11, 2024 | 3.69 | 3.965 | 3.62 | 3.94 | 531150.0 |
Apr 10, 2024 | 3.37 | 3.66 | 3.31 | 3.64 | 475411.0 |
Apr 09, 2024 | 3.46 | 3.592 | 3.38 | 3.43 | 327985.0 |
Apr 08, 2024 | 3.52 | 3.67 | 3.39 | 3.42 | 502651.0 |
Apr 05, 2024 | 3.12 | 3.47 | 3.11 | 3.43 | 440838.0 |
Apr 04, 2024 | 3.11 | 3.350 | 3.10 | 3.12 | 491246.0 |
Apr 03, 2024 | 3.00 | 3.205 | 2.995 | 3.15 | 332817.0 |
Apr 02, 2024 | 2.92 | 3.10 | 2.612 | 3.05 | 1.107M |
Apr 01, 2024 | 3.41 | 3.41 | 3.08 | 3.19 | 553413.0 |
Mar 28, 2024 | 3.49 | 3.505 | 3.355 | 3.45 | 332863.0 |
Mar 27, 2024 | 3.56 | 3.56 | 3.364 | 3.42 | 238020.0 |
Mar 26, 2024 | 3.47 | 3.581 | 3.405 | 3.46 | 192595.0 |
Mar 25, 2024 | 3.41 | 3.52 | 3.340 | 3.44 | 281230.0 |
Mar 22, 2024 | 3.60 | 3.65 | 3.40 | 3.40 | 396978.0 |
Mar 21, 2024 | 3.77 | 3.94 | 3.66 | 3.67 | 320342.0 |
Mar 20, 2024 | 3.62 | 3.81 | 3.52 | 3.77 | 271176.0 |
Mar 19, 2024 | 3.49 | 3.703 | 3.49 | 3.59 | 300326.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.08
Minimum
Oct 27 2023
23.53
Maximum
Feb 19 2021
9.715
Average
7.73
Median
Oct 14 2021
Price Benchmarks
Aspira Womens Health Inc | 3.35 |
Ardelyx Inc | 6.57 |
Panbela Therapeutics Inc | 0.42 |
Ensysce Biosciences Inc | 0.56 |
MAIA Biotechnology Inc | 2.48 |
Price Related Metrics
PEG Ratio | -0.0310 |
Price to Free Cash Flow | 2.588 |
Earnings Yield | -61.34% |
Market Cap | 177.59M |
PEGY Ratio | -0.0310 |